26 June 2020 | News
The company's focus is on high value human breast milk followed by cow milk
TurtleTree Labs Founders Max Rye and Fengru Lin
Singapore-based biotech company TurtleTree Labs has announced the completion of a fresh round of funding from global investors. TurtleTree Labs is the world's first-cell based biotechnology company creating real milk from mammalian cells, without the need for animals. As a platform, the company's focus is on high value human breast milk followed by cow milk.
With support from the Singaporean government, the startup has been privy to an array of resources that provided TurtleTree Labs with a tremendous financial boost, enabling it to continue working during the COVID-19 pandemic.
Co-founder Max Rye, originally from the San Francisco Bay area explains, "Our teams are firing on all cylinders thanks to Enterprise Singapore and the support from our investors. We remain as focused as ever, and we aim to continue hitting milestones."
"TurtleTree Labs' goal of creating milk from animal cells provides a novel solution towards sustainable dairy production globally, and would also help to strengthen Singapore's long-term food diversification efforts. We are encouraged that Singapore's foodtech infrastructure has enabled homegrown startups like TurtleTree Labs to push technological boundaries and obtain quick access to capital. We will continue our efforts to develop a vibrant agri-food tech ecosystem in Singapore to encourage the creation of more innovative solutions," said Ms Bernice Tay, Director, Food Manufacturing Division, Enterprise Singapore.